About Inositol polyphosphate-5-phosphatase A
Inositol polyphosphate-5-phosphatase A (INPP5A) is a protein
from Homo sapiens identified by UniProt accession
Q14642, 412 residues long.
MolForge cross-references it against 0 known binders and
102 disease associations.
Target properties
| Protein name | Inositol polyphosphate-5-phosphatase A |
| UniProt accession | Q14642 |
| Gene | INPP5A |
| Organism | Homo sapiens |
| Length | 412 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (102)
Diseases linked to this target (Open Targets).
- systolic blood pressure · score 0.50
- heel bone mineral density · score 0.50
- urate measurement · score 0.47
- neurodegenerative disease · score 0.46
- triglyceride measurement · score 0.46
- pulse pressure measurement · score 0.41
- bone quantitative ultrasound measurement · score 0.41
- hypertension · score 0.40
- cardiovascular disease · score 0.39
- hematocrit · score 0.33
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q14642-F1 | alphafold | PREDICTED | 91.38 | — |
Amino-acid sequence (412 residues)
MAGKAAAPGT AVLLVTANVG SLFDDPENLQ KNWLREFYQV VHTHKPHFMA LHCQEFGGKN YEASMSHVDK FVKELLSSDA MKEYNRARVY LDENYKSQEH FTALGSFYFL HESLKNIYQF DFKAKKYRKV AGKEIYSDTL ESTPMLEKEK FPQDYFPECK WSRKGFIRTR WCIADCAFDL VNIHLFHDAS NLVAWETSPS VYSGIRHKAL GYVLDRIIDQ RFEKVSYFVF GDFNFRLDSK SVVETLCTKA TMQTVRAADT NEVVKLIFRE SDNDRKVMLQ LEKKLFDYFN QEVFRDNNGT ALLEFDKELS VFKDRLYELD ISFPPSYPYS EDARQGEQYM NTRCPAWCDR ILMSPSAKEL VLRSESEEKV VTYDHIGPNV CMGDHKPVFL AFRIMPGAGK PHAHVHKCCV VQ
Explore Inositol polyphosphate-5-phosphatase A with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets